title: [Glycemia control in diabetic pregnancies under intensive insulin treatment with and without the aid of the Camit-Diacomp system].
abstract: The efficiency of glycemia control was compared in two groups of insulin dependent diabetic pregnancies treated with insulin, with and without the aid of the Camit-Diacomp system. The efficiency of glycemia control was analysed in all three trimesters of pregnancy. Mean diurnal fluctuations of glycemia levels in both study groups were compared. The clinical state of newborns, their glycemia and insulin levels in cord blood were analysed as well. No statistically significant differences of glycemia levels between the two compared groups of patients were found, however the observed significant differences of the HbA1C levels between these groups can speak in favour of the efficiency of treatment under the Camit-Diacomp system, which enables a more precise self control of the treatment and dosage of insulin.
authors.affiliation: Kliniki Intensywnego Nadzoru Instytutu Ginekologii i Połoznictwa AM im. K. Marcinkowskiego w Poznaniu.
authors.forename: E
authors.initials: E
authors.lastname: Wender-Ozegowska
authors.forename: E
authors.initials: E
authors.lastname: Nikisch
authors.forename: M
authors.initials: M
authors.lastname: Pietryga
authors.forename: W
authors.initials: W
authors.lastname: Meissner
authors.forename: K
authors.initials: K
authors.lastname: Hansz
authors.forename: E
authors.initials: E
authors.lastname: Biegańska
authors.forename: R
authors.initials: R
authors.lastname: Biczysko
mesh_terms: D002940:Circadian Rhythm; D003922:Diabetes Mellitus, Type 1 / Q000188:drug therapy*; D005260:Female; D005312:Fetal Blood / Q000737:chemistry; D006801:Humans; D007231:Infant, Newborn; D007328:Insulin / Q000008:administration & dosage* / Q000097:blood; D007332:Insulin Infusion Systems; D011247:Pregnancy; D011254:Pregnancy in Diabetics / Q000188:drug therapy*; D012646:Self Administration
chemical_list: D007328:Insulin
vernacular_title: Kontrola wyrównania glikemii u ciezarnych z cukrzyca leczonych intesywna insulinoterapia przy pomocy oraz bez systemu Camit-Diacomp.